DrugPatentWatch Database Preview
Novartis Company Profile
Summary for Novartis
| Patents: | 116 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| BLAs: | 1 |
| Patent Litigation for Novartis: | See patent lawsuits for Novartis |
| PTAB Cases with Novartis as patent owner: | See PTAB cases with Novartis as patent owner |
US Patents for Novartis
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Pharms Corp | ADAKVEO | crizanlizumab-tmca | INJECTABLE; INJECTION | 761128 | 001 | 2019-11-15 | RX | Orphan | ||||
| Novartis Pharms Corp | BEOVU | brolucizumab-dbll | INJECTABLE; INTRAVITREAL | 761125 | 001 | 2019-10-07 | RX | |||||
| Novartis Pharms Corp | COSENTYX | secukinumab | INJECTABLE;INJECTION | 125504 | 001 | 2016-01-15 | 9,744,234 | Novartis AG (Basel, CH) | 2030-11-05 | RX | search | |
| Novartis Pharms Corp | COSENTYX | secukinumab | INJECTABLE;INJECTION | 125504 | 001 | 2016-01-15 | 9,717,791 | Novartis AG (Basel, CH) | 2039-02-26 | RX | search | |
| Novartis Pharms Corp | COSENTYX | secukinumab | INJECTABLE;INJECTION | 125504 | 001 | 2016-01-15 | 9,707,154 | Corning Incorporated (Corning, NY) | 2033-04-24 | RX | search | |
| Novartis Pharms Corp | COSENTYX | secukinumab | INJECTABLE;INJECTION | 125504 | 001 | 2016-01-15 | 9,474,688 | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
